ERBB2 and gastric cancer: Several drug compounds are used in clinics to block ErbB2 signaling in the case of overexpression of ErbB2. Thus, a personalized treatment is available for patients with amplification of the ErbB2 gene (approved in clinical practice for breast and gastric cancer patients).